HH-01: Hyperkalemia in adults

XMLWordPrintable

    • Type: Hosp Inpt eCQMs - Hospital Inpatient eCQMs
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Elizabeth Ballard
    • 16678955398
    • MedStar Health
    • Hide
      Thank you for your question and comments about the Hospital Harm - Severe Hypoglycemia eCQM, CMS816. A severe hypoglycemic event is a glucose result of less than 40 mg/dL that occurs within 24 hours of administration of a hypoglycemic medication, such as insulin. The reason for administering the hypoglycemic medication, such as to treat hyperkalemia, is not considered in the evaluation because any severe hypoglycemic event is considered a harm. Treatment of severe hyperkalemia often involves insulin administration to drive potassium into the cells, primarily by enhancing the activity of the Na-K-ATPase pump in skeletal muscle. It is well recognized that hypoglycemia occurs in 6% to 18% of patients in this setting (https://pubmed.ncbi.nlm.nih.gov/27148740/, https://pubmed.ncbi.nlm.nih.gov/32979855/).
      Show
      Thank you for your question and comments about the Hospital Harm - Severe Hypoglycemia eCQM, CMS816. A severe hypoglycemic event is a glucose result of less than 40 mg/dL that occurs within 24 hours of administration of a hypoglycemic medication, such as insulin. The reason for administering the hypoglycemic medication, such as to treat hyperkalemia, is not considered in the evaluation because any severe hypoglycemic event is considered a harm. Treatment of severe hyperkalemia often involves insulin administration to drive potassium into the cells, primarily by enhancing the activity of the Na-K-ATPase pump in skeletal muscle. It is well recognized that hypoglycemia occurs in 6% to 18% of patients in this setting ( https://pubmed.ncbi.nlm.nih.gov/27148740/, https://pubmed.ncbi.nlm.nih.gov/32979855/) .
    • CMS0816v3
    • Patients are being included in the eCQM population due to insulin and D50 administration for the treatment of a life-threatening condition.

      Has consideration been given to evaluate a coded diagnosis of hyperkalemia to be an exclusion for the HH-01 measure? Treatment of severe hyperkalemia often includes the administration of insulin and glucose (D50) in order to lower the serum potassium concentration by driving potassium into the cells. 

            Assignee:
            Joelencia Leflore
            Reporter:
            Elizabeth D Ballard (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            4 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: